Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis

OBJECTIVES: Tolerogenic dendritic cells (tolDCs) constitute a promising experimental treatment for targeting autoreactive T cells in autoimmune diseases, including rheumatoid arthritis (RA). The authors' goal is to bring tolDC therapy for RA to the clinic. Here the authors address key translati...

Descripción completa

Detalles Bibliográficos
Autores principales: Harry, Rachel A, Anderson, Amy E, Isaacs, John D, Hilkens, Catharien M U
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2010
Materias:
Basic and Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002758/
https://www.ncbi.nlm.nih.gov/pubmed/20551157
http://dx.doi.org/10.1136/ard.2009.126383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002758/
https://www.ncbi.nlm.nih.gov/pubmed/20551157
http://dx.doi.org/10.1136/ard.2009.126383

Ejemplares similares